Australia · Delayed Price · Currency is AUD Noumi Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 8.8% to AUD 648.4 million and adjusted EBITDA rose 7.6% to AUD 61.8 million, with strong branded growth in both plant-based and dairy nutritionals. Statutory net loss narrowed to AUD 67.2 million, but significant debt maturities and market volatility remain key risks.
-
Record revenue and EBITDA growth driven by strong Plant-based Milks and Dairy & Nutritionals performance, with significant investments in marketing and innovation expected to fuel future gains. High leverage and commodity price volatility remain key risks as the company plans for 2027 note maturity.
Fiscal Year 2025
-
Adjusted operating EBITDA rose 13% to AUD 57.4 million, with strong plant-based and dairy segment growth. Statutory net loss was driven by non-cash items, while legacy issues are resolved and focus shifts to growth and capital planning for 2027 note maturity.
-
Record plant-based milk results and doubled dairy nutritionals earnings drove a 19% rise in adjusted EBITDA, despite a statutory net loss from significant one-off charges. Strong cash flow and working capital management support a positive outlook, with strategic investments in MILKLAB and innovation continuing.
Fiscal Year 2024
-
Record revenues and EBITDA were achieved, led by strong growth in plant-based milks and operational improvements, despite a statutory net loss driven by non-cash items and global dairy headwinds. The outlook remains cautious due to market volatility, but strategic execution and international expansion continue.